Showing results (411-420 of 1,190) with videos related to
Sort By:
Pageof 119
BMC Pharmacology & Toxicology|September 23, 2015
Effect of pegylated phosphatidylserine-containing liposomes in experimental chronic arthritisPaulo Cm Urbano, Vanete T Soccol, Vivian N Teixeira, et al.BMC Pharmacology & Toxicology|January 20, 2016
In vitro antibacterial activities of p-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypesArmelle T Mbaveng, Adriana Grozav Ignat, Bathélémy Ngameni, et al.BMC Pharmacology & Toxicology|September 30, 2015
Gloriosa superba poisoning mimicking an acute infection- a case reportRanjan Premaratna, Mindu S Weerasinghe, Nuwan P Premawardana, et al.BMC Pharmacology & Toxicology|December 5, 2014
Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitutionAshraf G Madian, Arun Panigrahi, Minoli A Perera, et al.BMC Pharmacology & Toxicology|November 30, 2014
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor bindingNicola Laurieri, Akane Kawamura, Isaac M Westwood, et al.BMC Pharmacology & Toxicology|November 21, 2014
Hydrocarbon molar water solubility predicts NMDA vs. GABAA receptor modulationRobert J Brosnan, Trung L PhamBMC Pharmacology & Toxicology|November 21, 2014
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluationEmma Loveman, Vicky R Copley, Jill L Colquitt, et al.BMC Pharmacology & Toxicology|September 11, 2020
1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells functionHuihan Ma, Qian Qin, Jiaqing Mi, et al.BMC Pharmacology & Toxicology|November 13, 2020
Broad Spectrum epidemiological contribution of cannabis and other substances to the teratological profile of northern New South Wales: geospatial and causal inference analysisAlbert Stuart Reece, Gary Kenneth HulseBMC Pharmacology & Toxicology|November 14, 2020
A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formationMin Jiang, Lixian Liu, Ruiwu Liu, et al.Pageof 119